HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling

This article was originally published in The Rose Sheet

Executive Summary

FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents

You may also be interested in...



CIR Panel To Consider Re-Reviewing AHA Safety As Use Rises

With use of alpha hydroxy acids in personal-care products on the upswing, the Cosmetic Ingredient Review Expert Panel will revisit the ingredient group’s safety report and consider re-opening a review at its next meeting.

Cosmetics Adverse Events Reported To FDA Increase 35% In FY 2012

The number of adverse events associated with cosmetics reported to FDA rose by nearly 100 between fiscal 2011 and 2012. The rise follows a push by the agency to increase awareness of the reporting program, but FDA cautions that may not solely be responsible for the higher numbers.

NCTR AHA Study Finds No Photocarcinogenic Affect Versus Control

The National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will discuss a draft report on the photocarcinogenicity of glycolic and salicylic acids during a Sept. 27-28 meeting in Research Triangle Park, N.C

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel